(2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Term ID

CHEBI:206275

Synonyms

(2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Definition

References

chemspider:9760481

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Phenotype where environments contain (2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Phenotype affecting (2S,3S,4S,5R,6S)-6-[(2R,3R,4S,5S)-4,5-diacetyloxy-2-[(2R,3R,4R,5R,6S)-5-hydroxy-6-[(2R,3R,4S)-4-hydroxy-2-[(1R)-1-hydroxyethyl]pyrrolidin-3-yl]oxy-2-(hydroxymethyl)-4-methoxyoxan-3-yl]oxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Human Disease Model